Stock MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Medical Developments International Limited

Equities

MVP

AU000000MVP2

Market Closed - Australian S.E.
Other stock markets
 07:10:03 08/07/2024 BST 		5-day change 1st Jan Change
0.5 AUD +16.28% Intraday chart for Medical Developments International Limited +26.58% -34.21%
04-29 Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
02-29 Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index
CI
Transcript : Medical Developments International Limited, 2023 Earnings Call, Aug 31, 2023
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Medical Developments International Limited Announces Resignation of David Williams from Board
CI
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
MT
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index
CI
Transcript : Medical Developments International Limited, H1 2023 Earnings Call, Feb 24, 2023
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%
MT
Medical Developments International Limited Discontinues China Clinical Trials
CI
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
CI
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022
CI
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
Rights Issue: 2 new shares @ 2 AUD for 19 existing shares
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MVP Stock
  4. News Medical Developments International Limited